Publicaciones en colaboración con investigadores/as de Uppsala University (6)

2020

  1. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  2. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    Cardiac Failure Review, Vol. 6

2016

  1. ESC 2015 guidelines for the treatment of patients with ventricular arrhythmias and prevention of sudden cardiac death

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 176e1-176e7

2015

  1. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)

    European Heart Journal, Vol. 36, Núm. 41, pp. 2793-2867l

  2. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)

    Europace, Vol. 17, Núm. 11, pp. 1601-1687

  3. Wytyczne ESC dotyczące postępowania u pacjentów z komorowymi zaburzeniami rytmu oraz zapobiegania nagłym zgonom sercowym w 2015 roku

    Kardiologia Polska, Vol. 73, Núm. 10, pp. 795-900